This study will test the safety of ipilimumab to see what effects, if any, the drug has when used as maintenance therapy for people with relapsed/refractory multiple myeloma who have received chemotherapy and allogeneic hematopoietic stem cell transplant (AHCT). The investigators also want to find out whether giving ipilimumab after chemotherapy and AHCT is a better way to control the multiple myeloma than chemotherapy and AHCT alone.
SparkCures ID | 1113 |
---|---|
Trial Phase | Phase 1/2 |
Enrollment | 45 Patients |
Treatments |
|
Tags |
|
Trial Sponsors |
|
Trial Collaborators |
|
NCT Identifier |
|
The following criteria is a partial list of reasons why patients may or may not be eligible to participate in this clinical trial. Further evaluation with a medical professional will be required to determine full eligibility.
The following criteria is provided for health care professionals.
Inclusion Criteria:
Inclusion Criteria prior to Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT):
Note:. A line of therapy is treatment between diagnosis and progression or between two progressions
Inclusion Criteria prior to Ipilimumab:
Exclusion Criteria:
Exclusion Criteria prior to Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT):
Patients ineligible for therapy with ipilimumab, for example:.
Exclusion Criteria prior to Ipilimumab:
The following is a listing of trial locations that are open and accepting patients.
New York, NY
Basking Ridge, NJ
Middletown, NJ
Montvale, NJ
Commack, NY
Uniondale, NY
West Harrison, NY
Basking Ridge, NJ
Middletown, NJ
Montvale, NJ
New York, NY
Commack, NY
Uniondale, NY
West Harrison, NY
There are no resources, links or videos to display for this clinical trial.
We know how difficult and confusing this process can be. If you are interested in this clinical trial or have questions, you can call us at any time. You can also send us a direct message with questions.
(888) 828-2206If you are interested in keeping an eye on this trial, you can add it to your list of favorite trials. We'll send you alerts when this trial is updated.
You can explore trial locations from around the US and connect directly with a trial coordinator.
Find Nearby LocationsYou can print an overview of this trial to take in to your next appointment. Your doctor can help you understand if this trial may be right for you.
Still need help? Send us a message
SparkCures is working closely with Memorial Sloan Kettering Cancer Center to provide the most up-to-date information on this clinical trial. Use the button above to add this trial to your list of favorites.
Learn more about how we work with trial sponsors